1. Ocular Therapeutics

    0 Comments Leave a Comment

    1-2 of 2
    1. Mentioned In 2 Articles

    2. Ocular Therapeutix™ Reports Changes to Board of Directors

      Ocular Therapeutix™ Reports Changes to Board of Directors
      Ocular Therapeutix, Inc.(NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announced the nomination of Seung Suh (Stanley) Hong, Ph.D. to the Board of Directors of the Company...
      Read Full Article
    3. Ocular Therapeutix™ Reports Election of Leslie Williams to Board of Directors

      Ocular Therapeutix™ Reports Election of Leslie Williams to Board of Directors
      BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced the election of Leslie J. Williams to the Board of Directors of the Company...
      Read Full Article
    4. 1-2 of 2
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content